|Other Retailer||Price Checked Time||Their Price in AUD||Our Price|
|Amazon UK||3 days ago||71.06||$62.72||You save $8.34|
|Amazon US||3 days ago||68.12||$62.72||You save $5.40|
Neuropharmacology and Drug Action Sarah E. Gartside and Charles A. Marsden Pharmacokinetics and Pharmacodynamics Ian M. Anderson Antipsychotics Frances Cheng, Peter B. Jones and Peter S. Talbot Antidepressants and ECT Chris Smart, Ian M. Anderson and R. Hamish McAllister-Williams `Mood Stabilisers' and Other Treatments for Bipolar Disorder Allan H. Young and Sarah C. Wooderson Anxiolytic and Hypnotic Drugs David S. Baldwin and Nupur Tiwari Drugs of Abuse Anne Lingford-Hughes and Mark Daglish Drugs for Dementia and Cognitive Impairment Mehran Javeed, Ian M. Anderson and Iracema Leroi Drugs Used for Personality Disorders and Behavioural Disturbance Birgit A. Voellm and Ian M. Anderson Drug Treatments for Child and Adolescent Disorders David R. Coghill Prescribing in Clinical Practice Peter M. Haddad and Angelika Wieck Clinical Trial Methodology Stephen M. Lawrie and R. Hamish McAllister-Williams
Edited by Ian M. Anderson, BA, MA, MBBS, MD, MRCP(UK), FRCPsych, is a professor of psychiatry in the Neuroscience and Psychiatry Unit at the University of Manchester, UK. He also is an honorary consultant psychiatrist at the Manchester Mental Health and Social Care Trust, UK. Dr. Anderson founded the Specialist Service for Affective Disorders in Manchester and was its director until 2011. His research interests include the aetiology and treatment of mood disorders, the mechanism of action of antidepressants and evidence-based psychiatry. He chaired the guideline development group for the 2009 update of the NICE depression clinical guideline and is an author on several consensus treatment guidelines from the British Association for Psychopharmacology (BAP). He is a past general secretary of the BAP. R. Hamish McAllister-Williams, BSc, MBChB, PhD, MD, FRCPsych, is a reader in clinical psychopharmacology at the Institute of Neuroscience in Newcastle University, UK. He is also an honorary consultant psychiatrist in the Regional Affective Disorders Service at the Northumberland Tyne and Wear NHS Foundation Trust, UK. Dr. McAllister-Williams is the lead consultant in the tertiary level Regional Affective Disorders Service based in Newcastle for patients with treatment-refractory mood disorders. His research focuses on the pathophysiology and treatment of both bipolar and unipolar affective disorders, and he is an author of the British Association for Psychopharmacology (BAP) consensus guidelines for treating depression. He is a past general secretary of the BAP and was appointed its director of education in 2012.
"Well-designed, well-written and well-edited reference book... a concise reference that achieves its stated aim of delivering an up-to-date review of the most current understanding of the state of psychopharmacology to meet the needs of the busy senior practitioner but also trainees." - (Winner of Psychiatry Category, BMA Medical Book Awards 2016) "This is an excellent resource that is easy to read, succinct but complete, and is based solely on research findings. I have read many psychopharmacology books, but this is one of the best because of how well it compiles a vast amount of information in short chapters. While the chapters about specific medications and conditions are well written, the chapters on research and basic prescribing practices are exceptional and complement the other chapters." -Aaron Plattner, MD, Doody's Book Reviews